ALT Blood Test: Check Your Liver Health
High ALT levels may point to liver damage or disease. Early detection helps prevent serious health complications.
July 2, 2024
What Is Alanine Transaminase (ALT)?
Alanine transaminase (ALT) is an enzyme found predominantly inside liver cells. It catalyzes the transfer of an amino group from alanine to alpha-ketoglutarate, producing pyruvate and glutamate — a reaction that feeds into energy metabolism and glucose synthesis. Under normal conditions, ALT stays inside hepatocytes. When liver cells are damaged or inflamed, the cell membranes lose integrity and ALT leaks into the bloodstream, where it shows up on a routine blood draw.
While ALT is present in smaller amounts in the kidneys, heart, and skeletal muscle, the liver contains the highest concentration by a wide margin. That concentration is what makes ALT a more specific marker of liver injury than its companion enzyme, aspartate transaminase (AST), which is distributed more broadly throughout body tissues. When a clinician sees elevated ALT, the liver is the primary structure under investigation.
ALT is measured as part of the comprehensive metabolic panel (CMP) and the liver function test (LFT). Because the enzyme responds sensitively to hepatocyte damage, it is used to screen for conditions ranging from fatty liver disease to viral hepatitis to drug-induced liver injury. A normal result is genuinely useful information; an elevated one prompts further workup.
The enzyme requires vitamin B6 (pyridoxal phosphate) as a cofactor. This is why chronic B6 deficiency or poor nutritional status can produce artificially low ALT readings — a detail worth keeping in mind when interpreting unexpectedly low values in certain patient populations.
Clinicians typically interpret ALT alongside AST, alkaline phosphatase (ALP), and bilirubin to get a more complete picture of liver health. Patterns across several markers are more informative than any single value alone. For a broader view of how these enzymes relate to one another, see the Mito Health biomarker library.
Normal Reference Range
Most clinical laboratories set the reference range for ALT at approximately 7 to 56 U/L (units per liter), though this varies between labs and testing platforms. Results near the upper boundary are worth noting even when technically in range, particularly in people with metabolic risk factors such as obesity, insulin resistance, or elevated triglycerides.
Reference ranges are not uniform across all groups. Men tend to have higher baseline ALT levels than women, due in part to differences in body composition and hormonal influences. Many laboratories now apply sex-specific cutoffs to improve clinical accuracy. A widely cited analysis published in the Annals of Internal Medicine proposed tighter thresholds — below 30 U/L for men and below 19 U/L for women — on the basis that traditional upper limits allowed early liver disease to go undetected in a meaningful portion of the population [Prati et al., 2002]. Some hepatologists use these lower cutoffs when evaluating patients with metabolic risk.
Age matters as well. Infants and children have higher ALT levels than adults, reflecting normal developmental physiology rather than pathology. In older adults, decreased muscle mass and slower enzyme turnover can shift levels lower. Any interpretation of ALT should account for the individual’s age, sex, medications, and overall clinical context.
What High Alanine Transaminase (ALT) Levels Mean
Elevated ALT is among the most common incidental findings on routine blood panels. A mild elevation — one to three times the upper limit of normal — is frequently caused by lifestyle factors or early-stage conditions that respond well to intervention. Moderate elevations of three to ten times normal point more strongly toward active liver disease or significant toxin exposure. Values greater than ten times normal are considered severe and typically reflect acute hepatitis or serious liver injury requiring prompt medical evaluation.
Common causes of elevated ALT include:
Non-alcoholic fatty liver disease (NAFLD) — accumulation of fat in liver cells driven by metabolic factors such as obesity, insulin resistance, and elevated triglycerides; the leading cause of mildly elevated ALT in adults across most developed countries
Alcohol-related liver disease — chronic or heavy drinking damages hepatocytes and raises ALT, often with a disproportionate rise in AST relative to ALT
Viral hepatitis — hepatitis A, B, and C each cause hepatocyte inflammation and ALT elevation, with acute infection producing the most pronounced spikes
Medications and supplements — acetaminophen (especially in overdose or combined with alcohol), statins, some antibiotics, antifungals, and certain herbal products are recognized causes of drug-induced liver injury
Intense or unaccustomed exercise — heavy resistance training or prolonged aerobic effort causes muscle fiber micro-damage that temporarily raises ALT along with other muscle enzymes such as creatine kinase
Systemic conditions — hypothyroidism, celiac disease, and right-sided heart failure can each elevate ALT through indirect mechanisms
A persistently elevated ALT — confirmed on repeat testing at least four weeks apart — should not be ignored, even when the elevation is mild. Early NAFLD and other hepatic conditions are often asymptomatic, and an earlier diagnosis leaves more treatment options available.
One nuance worth knowing: ALT does not always track linearly with disease severity. In advanced cirrhosis, so many functional liver cells have been lost that ALT can return to the normal range — not because the liver has recovered, but because there is little remaining active tissue to release the enzyme. A normal ALT in a patient with known liver disease is not automatically reassuring.
What Low Alanine Transaminase (ALT) Levels Mean
Low ALT — typically below 7 U/L — gets less attention than elevated values but is not always benign. In many individuals it reflects natural variation, low muscle mass, or a high level of physical fitness. In others it points to nutritional or metabolic conditions worth addressing.
Recognized causes of low ALT include:
Vitamin B6 deficiency — since ALT requires pyridoxal phosphate as a cofactor, inadequate B6 intake directly reduces measured enzyme activity in plasma
Chronic kidney disease — patients on hemodialysis consistently show lower ALT levels, likely due to altered hepatic enzyme synthesis and accelerated clearance
Protein-energy malnutrition — reduced substrate availability and impaired liver synthetic function both contribute to lower enzyme levels in undernourished individuals
Hypothyroidism — thyroid hormones regulate the expression of many hepatic enzymes; reduced thyroid activity can suppress ALT production
Advanced age with significant sarcopenia — loss of skeletal muscle reduces the baseline muscle-derived contribution to circulating ALT
Some large population studies have found that very low ALT is associated with higher all-cause mortality, particularly in older adults — most likely reflecting underlying malnutrition or systemic illness rather than optimal metabolic health. If your ALT is consistently below the reference range alongside symptoms such as fatigue, unintentional weight loss, or weakness, a nutritional workup is a reasonable next step.
How to Optimize Your Alanine Transaminase (ALT) Naturally
For most people with mildly elevated ALT, lifestyle changes are the best-supported first step. The conditions most commonly responsible — NAFLD and alcohol-related inflammation in particular — respond well to sustained behavioral changes. Reducing body weight by five to ten percent has been shown to lower ALT and reduce liver fat in people with metabolic liver disease [Vilar-Gomez et al., 2015]. The changes do not need to be dramatic to show up on bloodwork.
Diet matters considerably. A Mediterranean-style eating pattern — olive oil, vegetables, legumes, fatty fish, and whole grains, with less refined carbohydrate and ultra-processed food — has shown liver health benefits in clinical studies. Cutting fructose is particularly relevant; high intake from sweetened beverages and processed snacks drives hepatic fat accumulation through de novo lipogenesis. Reducing or eliminating alcohol is essential when drinking is a contributing factor. Coffee has been associated in multiple observational studies with lower liver enzyme levels and reduced fibrosis progression, though the mechanism and magnitude of benefit remain under active investigation.
Both aerobic and resistance training reduce hepatic fat content independent of weight loss, so physical activity helps even without a change on the scale. For supplements, vitamin E at 800 IU per day produced statistically significant reductions in ALT in patients with confirmed non-alcoholic steatohepatitis (NASH) in a randomized controlled trial [Sanyal et al., 2010]. At that dose, supplementation is best done with medical supervision given ongoing questions about long-term safety.
For a detailed, actionable guide covering nutrition, exercise, and targeted supplementation strategies, see the Mito Health resource: how to improve your alanine transaminase (alt) naturally.
Testing and Monitoring
ALT is measured through a standard blood draw and is included in both the basic metabolic panel (BMP) and the comprehensive metabolic panel (CMP). Strict fasting is not required for ALT specifically, but most labs recommend avoiding heavy meals for 8 to 12 hours beforehand to reduce variability in related markers tested at the same time. Avoid intense exercise for 24 to 48 hours before your blood draw — vigorous physical activity can transiently raise ALT through muscle enzyme release, which may confound interpretation of the result.
How often to retest depends on your baseline and clinical context. Adults with no known liver disease and a normal result on a routine panel can reasonably check annually. If your ALT is mildly elevated, a repeat test 4 to 8 weeks later — after addressing obvious contributors such as alcohol, sedentary behavior, or recent high-intensity exercise — is a practical first step before pursuing further investigation. For those managing a diagnosed condition such as NAFLD, testing every 3 to 6 months lets clinicians track how the liver is responding to lifestyle or medical treatment.
Mito Health’s comprehensive blood panel includes ALT alongside more than 100 biomarkers — covering metabolic health, cardiovascular risk, hormones, thyroid function, and more — for $349 for an individual or $668 for a duo. Viewing ALT in context with AST, GGT, ALP, and bilirubin provides a far richer picture of liver health than a single enzyme value reviewed in isolation.
Frequently Asked Questions
Q: Can a hard workout make my ALT look high on a blood test?
A: Yes. Intense resistance training or prolonged endurance exercise causes micro-damage to muscle fibers, releasing enzymes — including ALT — into the bloodstream. The elevation is usually mild and resolves within 24 to 72 hours. If you had a demanding workout in the days before your draw, mention it to your clinician. Retesting after a few days of rest can clarify whether the elevation is exercise-related or reflects a liver issue.
Q: What is the difference between ALT and AST?
A: Both are liver enzymes, but they differ in distribution and specificity. ALT is concentrated primarily in the liver, making it a more targeted marker of hepatic injury. AST is found in higher amounts in heart muscle, skeletal muscle, and red blood cells as well, so it is less liver-specific. The ratio of AST to ALT is itself clinically informative: a ratio above 2:1 is associated with alcohol-related liver disease, while a ratio below 1:1 is more typical of NAFLD.
Q: My ALT is just slightly above the reference range. Should I be worried?
A: A mildly elevated value — say, 60 U/L when the upper limit is 56 — is worth taking seriously but not a reason for immediate alarm. A sensible first step is a repeat test after a few weeks, ideally following some dietary improvement, reduced alcohol intake, and increased physical activity if relevant. Persistent elevation across two or more measurements warrants further workup; a single above-range value often resolves on its own. Work with your clinician to determine the right next step based on your full clinical picture.
Q: Can medications cause elevated ALT without any symptoms?
A: Yes. Drug-induced liver injury frequently presents with elevated ALT and no symptoms at all, particularly in early stages. Statins, NSAIDs, certain antibiotics, antifungals, and some herbal or dietary supplements are common contributors. If you started a new medication or supplement shortly before noticing an elevated ALT, inform your prescribing clinician. In many cases, switching to a different drug class allows ALT to normalize without lasting consequences.
